Tags

Type your tag names separated by a space and hit enter

Integrated genomic characterization of papillary thyroid carcinoma.
Cell. 2014 Oct 23; 159(3):676-90.Cell

Abstract

Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Here, we describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic alterations (relative to other carcinomas) and extended the set of known PTC driver alterations to include EIF1AX, PPM1D, and CHEK2 and diverse gene fusions. These discoveries reduced the fraction of PTC cases with unknown oncogenic driver from 25% to 3.5%. Combined analyses of genomic variants, gene expression, and methylation demonstrated that different driver groups lead to different pathologies with distinct signaling and differentiation characteristics. Similarly, we identified distinct molecular subgroups of BRAF-mutant tumors, and multidimensional analyses highlighted a potential involvement of oncomiRs in less-differentiated subgroups. Our results propose a reclassification of thyroid cancers into molecular subtypes that better reflect their underlying signaling and differentiation properties, which has the potential to improve their pathological classification and better inform the management of the disease.

Authors+Show Affiliations

Cancer Genome Atlas Program Office, National Cancer Institute at NIH, 31 Center Drive, Bldg. 31, Suite 3A20, Bethesda MD 20892, USA. giordano@umich.edu

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

25417114

Citation

Cancer Genome Atlas Research Network. "Integrated Genomic Characterization of Papillary Thyroid Carcinoma." Cell, vol. 159, no. 3, 2014, pp. 676-90.
Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159(3):676-90.
Cancer Genome Atlas Research Network. (2014). Integrated genomic characterization of papillary thyroid carcinoma. Cell, 159(3), 676-90. https://doi.org/10.1016/j.cell.2014.09.050
Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Papillary Thyroid Carcinoma. Cell. 2014 Oct 23;159(3):676-90. PubMed PMID: 25417114.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Integrated genomic characterization of papillary thyroid carcinoma. A1 - ,, PY - 2014/05/11/received PY - 2014/09/16/revised PY - 2014/09/23/accepted PY - 2014/11/24/entrez PY - 2014/11/25/pubmed PY - 2015/3/12/medline SP - 676 EP - 90 JF - Cell JO - Cell VL - 159 IS - 3 N2 - Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Here, we describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic alterations (relative to other carcinomas) and extended the set of known PTC driver alterations to include EIF1AX, PPM1D, and CHEK2 and diverse gene fusions. These discoveries reduced the fraction of PTC cases with unknown oncogenic driver from 25% to 3.5%. Combined analyses of genomic variants, gene expression, and methylation demonstrated that different driver groups lead to different pathologies with distinct signaling and differentiation characteristics. Similarly, we identified distinct molecular subgroups of BRAF-mutant tumors, and multidimensional analyses highlighted a potential involvement of oncomiRs in less-differentiated subgroups. Our results propose a reclassification of thyroid cancers into molecular subtypes that better reflect their underlying signaling and differentiation properties, which has the potential to improve their pathological classification and better inform the management of the disease. SN - 1097-4172 UR - https://www.unboundmedicine.com/medline/citation/25417114/full_citation DB - PRIME DP - Unbound Medicine ER -